Oramed Pharmaceuticals Inc (ORMP) — Financial Flexibility Index
Oramed Pharmaceuticals Inc (ORMP) has a Financial Flexibility Index of -0.10x as of March 2026. Free cash flow of $-2.91 Million (operating CF $-2.92 Million minus capex $5.00K) represents 0% of total liabilities ($30.57 Million). Check Oramed Pharmaceuticals Inc (ORMP) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oramed Pharmaceuticals Inc Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Oramed Pharmaceuticals Inc across 22 annual periods. See Oramed Pharmaceuticals Inc (ORMP) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Oramed Pharmaceuticals Inc (2003–2025)
Year-by-year free cash flow to debt coverage for Oramed Pharmaceuticals Inc. For the full company profile including market capitalisation, see ORMP stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | $-7.21 Million | $-9.14 Million | $31.12 Million | ▲ +72.6% |
| 2024 | -0.85x | $-8.39 Million | $-8.41 Million | $9.93 Million | ▼ -385.4% |
| 2023 | -0.17x | $-10.04 Million | $-10.29 Million | $57.66 Million | ▲ +93.5% |
| 2022 | -2.69x | $-28.21 Million | $-28.70 Million | $10.49 Million | ▼ -48.4% |
| 2021 | -1.81x | $-20.81 Million | $-21.18 Million | $11.48 Million | ▼ -72.3% |
| 2020 | -1.05x | $-12.36 Million | $-12.44 Million | $11.75 Million | ▼ -24.2% |
| 2019 | -0.85x | $-12.93 Million | $-12.94 Million | $15.27 Million | ▲ +5.9% |
| 2018 | -0.90x | $-14.65 Million | $-14.66 Million | $16.29 Million | ▼ -200.8% |
| 2017 | -0.30x | $-5.82 Million | $-5.83 Million | $19.47 Million | ▼ -206.7% |
| 2016 | 0.28x | $4.66 Million | $4.66 Million | $16.64 Million | ▲ +108.6% |
| 2015 | -3.24x | $-4.95 Million | $-4.95 Million | $1.53 Million | ▲ +19.3% |
| 2014 | -4.02x | $-4.05 Million | $-4.07 Million | $1.01 Million | ▲ +37.2% |
| 2013 | -6.40x | $-3.39 Million | $-3.40 Million | $529.41K | ▼ -322.3% |
| 2012 | -1.52x | $-2.30 Million | $-2.30 Million | $1.52 Million | ▲ +45.1% |
| 2011 | -2.76x | $-1.66 Million | $-1.67 Million | $602.02K | — |
| 2010 | 0.00x | $0.00 | $-1.42 Million | $620.62K | ▲ +100.0% |
| 2009 | -4.35x | $-2.25 Million | $-2.25 Million | $515.66K | ▼ -130.7% |
| 2008 | -1.89x | $-1.72 Million | $-1.84 Million | $913.95K | ▼ -341.3% |
| 2007 | -0.43x | $-609.00K | $-611.00K | $1.42 Million | ▲ +28.0% |
| 2006 | -0.59x | $-361.61K | $-361.61K | $608.91K | ▲ +32.3% |
| 2005 | -0.88x | $-40.43K | $-40.44K | $46.07K | ▲ +78.1% |
| 2003 | -4.00x | $-40.00K | $-40.00K | $10.00K | — |